THURSDAY, 30 JUNE, 2016 FRIDAY, 1 JULY 2016

Transcription

1 THURSDAY, 30 JUNE, :00 18:30 OPENING CEREMONY Opening Lecture: TBA 18:30 19:30 Chairs: Maciej Banach (); Nathan D. Wong (Irvine, USA) 19:30 Get Together Reception FRIDAY, 1 JULY :30 - Plenary Chairs: Nanette Wenger (Atlanta, USA), Maciej Banach () Cardiovascular Disease Risk Assessment in Older Adults 08:30 09:15 Nathan D. Wong Irvine, USA Prevention of CVD in the Elderly should begin before we are Elderly 09:15 10:00 Allan Sniderman Montreal Canada 10:00 10:30 Tea/ Coffee Break 10:30 LIPID Lowering Therapy 10:30 Diabetes and its complications 10:30 11:00 Chair: Allan Sniderman (Montreal Canada) Treatment of dyslipidemia in elderly patients with coronary heart disease: there are miles to go before we sleep. Peter P. Toth Chicago, USA Chair: Adrian Covic (Iasi, Romania) 10:30 11:00 Novel therapies for type-2 diabetes in pre-elderly and the elderly. Manfredi Rizzo Palermo, Italy

2 11:00 11:30 12:00 12:30 Statins and cardiovascular prevention in the elderly Dimitri P. Mikhailidis London, UK PCSK9 inhibitors for elderly patients? Another lack of evidence or effective therapy for older adults with high CV risk? Maciej Banach 12:00-12:30 12:30 14:00 Lunch 11:00 11:30 The Differential Effect of Atherosclerosis on End Organ Damage in adults and elderly patients with CVRF. Which group is on the highest risk of MI and stroke? Reuven Zimlichman Tel-Aviv, Israel HF management in the elderly Chair: Peter P. Toth (Chicago, USA) Nutraceuticals Chair: Corina Serban (Birmingham, AL, USA/) Blood pressure lowering and prevention of heart failure Alberto Zanchetti Milan, Italy COPD as a co-morbidity of HF. in elderly patients. Mitja Lainscak Celje, Slovenia Clinical impact of muscle wasting in heart failure. Stephan von Haehling Berlin, Germany Nutraceuticals in Lipid-Lowering Treatment. Manfred Rizzo Palermo, Italy Role of micronutrients and nutraceuticals in chronic heart failure. Daniel Pella Kosice, Slovak Republic 15:30 16:00 Tea/ Coffee Break, Exhibition and Poster Viewing 16:00 17:30 16:00-16:30 16:30 17:00 Lipids Chair: Manfredi Rizzo (Palermo, Italy) Irrefragable Evidence ApoB is a better marker of cardiovascular risk than LDL-C of non-hdl-c. Allan Sniderman, Montreal, Cananda Lipid Disorders therapy in older adults without cardiovascular disease. What do we know? Karam Kostner, 16:00 17:30 16:00 16:30 Renal Disease Chair: Lucian Petrescu () Effective Hypertension in older adults with chronic kidney disease. Many missing links? Jacek Rysz Dialysis modality choice in elderly patients with end-stage renal disease. Adrian Covic Iasi, Romania

3 Queensland, Australia 17:30 18:00 Non Cardiac Arterial disease and lipids in the elderly. Dimitri P. Mikhailidis London, UK SATURDAY, 2 JULY 2016 Plenary Chairs: Alberto Zanchetti (Milan, Italy), Franz Messerli (NY, USA) Clinical Pearls: Diagnostic Dilemmas in Cardiovascular Disease at Elderly Age. 08:30 09:15 Nanette Wenger, Atlanta, USA Hypertension Control in Older Adults: Implications of New US Guidelines and the SPRINT Trial 09:15 10:00 Nathan Wong Irvine, CA, USA 10:00 10:30 Tea/ Coffee Break, Exhibition and Poster Viewing 10:30 11:00 Stroke / Hypertenstion 10:30 11:00 Cardiovascular Interventions Chair: Maciej Banach () Chair: Stephan von Haehling (Berlin, Germany) 10:30-11:00 Hypertension Facts, Fiction and Follies Franz Messerli New York, USA 10:30-11:00 Percutaneous coronary Interventions in elderly. When, whom, how? What about novel methods, including bioresorbable stents? Daniel Brie 11:00 11:30 CHD in older adults in the 21 st century; findings from the REGARDS-MI study. Monika Safford Birmingham, AL, USA 11:00 11:30 Monoamine oxidase contribution to cardiovascular dysfunction in coronary patients undergoing surgical revascularization. Danina Muntean 12:30 14:00 Lunch 13:30 14:00 Special lecture: How to write a paper! Dimitri P. Mikhailidis, London, UK

4 Challenges in Elderly Chair: Monika Safford (Birmingham, AL, USA) The Healthy Aging Research Centre (HARC) Session Chair: Nanette Wenger (Atlanta, USA) Cardiovascular Prevention at Elderly Age Is it Ever Too Late? Nanette K. Wenger Atlanta, GA, USA Depression and CVD risk in the elderly Tomasz Sobow 14: 30-15:00 How to decrease heart dysfunction with suitable therapy of pulmonary diseases. Wojciech Piotrowski Aging, and Physical activity, and cardiovascular prevention? Tomasz Kostka Therapy challenges Chair: Dimitri P. Mikhailidis (London, UK) Arrythmias prevention and therapy Chair: Daniel Pella (Kosice, Slovak Republic) :30 16: Polypharmacy and polypragmasy in elderly cardiovascular patients. Daniel Pella Kosice, Slovak Republic Statin therapy in elderly. From lack of EBM, statin intolerance to quality of life. Maciej Banach :30 16: Supraventricular arrhythmias management in the elderly state of knowledge. Daniel Lighezan Antithrombotic therapy in the elderly patients Lucian Petrescu Tea/ Coffee Break, Exhibition and Poster Viewing :00 Closing

5